Clinical Trial Update: The Value of a Risk Prediction Tool (PERSARC) for Effective Treatment Decisions of Soft-tissue Sarcomas Patients [NA]

View source ↗

Summary

A clinical trial update notes an active-not-recruiting study evaluating PERSARC, a risk-prediction tool, to guide treatment decisions in soft-tissue sarcoma pat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Snippet

Sponsor: Leiden University Medical Center | Conditions: Soft-tissue Sarcoma, Predictive Cancer Model | NA | Status: ACTIVE_NOT_RECRUITING